These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16430066)

  • 21. Recurrent endometrial carcinoma: prognosis for patients with recurrence within 6 to 12 months is worse relative to those relapsing at 12 months or later.
    Miyake T; Ueda Y; Egawa-Takata T; Matsuzaki S; Yokoyama T; Miyoshi Y; Kimura T; Yoshino K; Fujita M; Yamasaki M; Enomoto T; Kimura T
    Am J Obstet Gynecol; 2011 Jun; 204(6):535.e1-5. PubMed ID: 21481836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Combination chemotherapy with paclitaxel and carboplatin (TC therapy) for endometrial cancer].
    Misawa A; Nagao M; Kushimoto T; Yasuda M
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1901-5. PubMed ID: 19011339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
    Hurst SA; Hartzfeld KM; Del Priore G
    Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.
    Fracasso PM; Blessing JA; Molpus KL; Adler LM; Sorosky JI; Rose PG
    Gynecol Oncol; 2006 Nov; 103(2):523-6. PubMed ID: 16712905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck.
    Colevas AD
    J Clin Oncol; 2006 Jun; 24(17):2644-52. PubMed ID: 16763278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel, epirubicin, and carboplatin in advanced or recurrent endometrial carcinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.
    Papadimitriou CA; Bafaloukos D; Bozas G; Kalofonos H; Kosmidis P; Aravantinos G; Fountzilas G; Dimopoulos MA;
    Gynecol Oncol; 2008 Jul; 110(1):87-92. PubMed ID: 18455782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is single-agent chemotherapy acceptable in platinum-sensitive relapsed ovarian cancer?
    Abou-Jawde RM; Oberoi SS
    J Clin Oncol; 2008 May; 26(15):2602-3; author reply 2603. PubMed ID: 18487582
    [No Abstract]   [Full Text] [Related]  

  • 28. Haematological evaluation of weekly therapy with topotecan for the treatment of recurrent ovarian cancer resistant to platinum-based therapy.
    Largillier R; Valenza B; Ferrero JM; Novo C; Creisson A; Lesbats G; Mari V; Hebert C; Chamorey E
    Oncology; 2007; 73(3-4):177-84. PubMed ID: 18418010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiologic profile of gastric carcinoma: study of 140 cases].
    Arfaoui D; Elloumi H; Hamila F; Gouma M; Ben Abdellaziz A; Sfar S; Jmaa A; Gannem H; Bel Hadj HR; Ajmi S
    Tunis Med; 2006 May; 84(5):301-4. PubMed ID: 16915781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adjuvant chemotherapy for colon cancer].
    Dahl O
    Tidsskr Nor Laegeforen; 2007 Nov; 127(23):3094-6. PubMed ID: 18049502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant carboplatin and paclitaxel chemotherapy interposed with involved field radiation for advanced endometrial cancer.
    Lupe K; D'Souza DP; Kwon JS; Radwan JS; Harle IA; Hammond JA; Carey MS
    Gynecol Oncol; 2009 Jul; 114(1):94-8. PubMed ID: 19406459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
    Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral arterial thrombosis induced by chemotherapy in ovarian carcinoma coexisted with endometrial carcinoma.
    Hida K; Ikeda S; Shimizu S; Yoshikata R; Orito S; Tatsuduki A; Ohta H
    Arch Gynecol Obstet; 2007 Jan; 275(1):63-5. PubMed ID: 16767460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sparing fertility in young patients with endometrial cancer.
    Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy of metastatic endometrial cancer.
    Muss HB
    Semin Oncol; 1994 Feb; 21(1):107-13. PubMed ID: 8310301
    [No Abstract]   [Full Text] [Related]  

  • 37. Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management.
    Grønlund B
    Dan Med Bull; 2006 Aug; 53(3):232-57. PubMed ID: 17092448
    [No Abstract]   [Full Text] [Related]  

  • 38. Another example of the highly variable clinical course of recurrent/resistant/persistent ovarian cancer.
    Markman M
    Cancer Invest; 2006 Feb; 24(1):109. PubMed ID: 16467001
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential use of the adenosine triphosphate cell viability assay in endometrial cancer.
    Tam KF; Ng TY; Tsang PC; Li CF; Ngan HY
    J Soc Gynecol Investig; 2006 Oct; 13(7):518-22. PubMed ID: 16979354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
    Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.